These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 932422)

  • 1. Studies on the terminal stages of antibody-complement mediated killing of a tumor cell. III. Effect of membrane active agents.
    Boyle MD; Ohanian SH; Borsos T
    J Immunol; 1976 Jul; 117(1):106-9. PubMed ID: 932422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the terminal stages of antibody-complement-mediated killing of a tumor cell. II. Inhibition of transformation of T to dead cells by 3'5' cAMP.
    Boyle MD; Ohanian SH; Borsos T
    J Immunol; 1976 May; 116(5):1276-9. PubMed ID: 178794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the terminal stages of antibody-complement-mediated killing of a tumor cell. I. Evidence for the existence of an intermediate, T.
    Boyle MD; Ohanian SH; Borsos T
    J Immunol; 1976 May; 116(5):1272-5. PubMed ID: 178793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysis of tumor cells by antibody and complement. III. Lack of correlation between antigen movement and cell lysis.
    Boyle MD; Ohanian SH; Borsos T
    J Immunol; 1975 Aug; 115(2):473-5. PubMed ID: 50364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of concanavalin A on the killing of tumor cells by antibody and complement.
    Boyle MD; Langone JJ; Ohanian SH; Borsos T
    J Immunol; 1977 May; 118(5):1626-30. PubMed ID: 192797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral immune killing of nucleated cells: mechanisms of complement-mediated attack and target cell defense.
    Ohanian SH; Schlager SI
    Crit Rev Immunol; 1981 Jan; 1(3):165-209. PubMed ID: 6174273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reticulum cell sarcoma: an effector cell in antibody-dependent cell-mediated immunity.
    Ralph P; Prichard J; Cohn M
    J Immunol; 1975 Feb; 114(2 pt 2):898-905. PubMed ID: 1089721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased sensitivity of human leukemic granulocytes to heterophil antibody in normal rabbit sera.
    Bases R; Mendez F; Clark J; Rosenberg A; Milstein D
    J Natl Cancer Inst; 1970 May; 44(5):993-1000. PubMed ID: 5285265
    [No Abstract]   [Full Text] [Related]  

  • 9. [The complement system].
    Wellensiek HJ
    Verh Dtsch Ges Pathol; 1970; 54():37-52. PubMed ID: 4104569
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the terminal stages of immune hemolysis. VI. Osmotic blockers of differing Stokes' radii detect complement-induced transmembrane channels of differing size.
    Boyle MD; Gee AP; Borsos T
    J Immunol; 1979 Jul; 123(1):77-82. PubMed ID: 109541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperation and cell-mediated cytotoxicity as functions of two subsets of T cells.
    Dennert G; Lennox ES
    J Immunol; 1974 Nov; 113(5):1553-61. PubMed ID: 4213868
    [No Abstract]   [Full Text] [Related]  

  • 12. Sheep serum complement sensitisation of sheep erythrocyte-rabbit antibody complexes for haemolysis by guinea-pig complement plus EDTA or Mg2+-EGTA.
    Jonas W; Stankiewicz M
    Arch Immunol Ther Exp (Warsz); 1986; 34(4):451-60. PubMed ID: 3099725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The target cell for antilymphocyte antibodies in Hodgkin's disease].
    Del Giacco GS; Manconi PE; Tognella S; Mantovani G; Turno R; Grifoni V
    Boll Ist Sieroter Milan; 1974; 53(4):562-4. PubMed ID: 4615725
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody-mediated cell cytotoxicity in a defined system: regulation by antigen, antibody, and complement.
    Lustig HJ; Bianco C
    J Immunol; 1976 Jan; 116(1):253-60. PubMed ID: 1245741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma membrane and intracellular lipid synthesis in tumor cells rendered resistant to humoral immune killing after treatment with hormones.
    Schlager SI; Ohanian SH
    J Natl Cancer Inst; 1980 Apr; 64(4):943-50. PubMed ID: 6988626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-dependent lymphoid cell-mediated cytotoxicity: role of complement.
    Van Boxel JA; Paul WE; Green I; Frank MM
    J Immunol; 1974 Jan; 112(1):398-403. PubMed ID: 4812178
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of metabolic inhibitors on the ability of tumor cells to express antigen and bind complement components C4 and C3.
    Segerling M; Ohanian SH; Borsos T
    Cancer Res; 1975 Nov; 35(11 Pt 1):3204-8. PubMed ID: 52405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of macrophage-like characteristics in a cultured murine tumor line.
    Koren HS; Handwerger BS; Wunderlich JR
    J Immunol; 1975 Feb; 114(2 pt 2):894-7. PubMed ID: 1167564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of complement-mediated membrane damage: the influence of erythrocyte storage on susceptibility to cytolysis.
    Gaither TA; Frank MM
    J Immunol; 1973 Feb; 110(2):482-9. PubMed ID: 4684035
    [No Abstract]   [Full Text] [Related]  

  • 20. Complement: effects of C1 binding affinity on the efficiency of the C2 reaction.
    Linscott WD
    J Immunol; 1972 Dec; 109(6):1327-36. PubMed ID: 4673616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.